In accordance with the Food and Drug Safety Administration's change order for pharmaceutical manufacturing (import) items (Drug Management Division-No. 8702, effective date 2009.9.7), the precautions for use of Gabapen capsules and Repoxin tablets have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Gabapen capsule, Repoxin tablet
Attachments are original documents and may be in Korean. English editions are labeled separately.
Gabapen Capsule.hwp9. Change order for permission (Gabapen Capsule) (2009. 09.07).hwp · 82 KBDownload ↓